Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Interventional 12 Observational 1

Sponsor

Cancer Type

Breast 4 Other hematologic neoplasm 2 Head & Neck 2 Tumor-Agnostic 1 Thoracic 1 Other 1 Gynecologic 1 Genitourinary 1 Gastrointestinal 1

Conditions

Obesity 1 Neoplasms 1 Motor Activity 1

Interventions

Surveys and Questionnaires 9 Blood Specimen Collection 5 naloxegol 3 Therapeutics 3 Observation 3 Interviews as Topic 3 Bariatric Surgery 3 naldemedine 2 exemestane 2 Tirzepatide 2 Tamoxifen 2 Psychiatric Rehabilitation 2 Paclitaxel 2 Hematologic Tests 2 Esophagectomy 2 Echocardiography 2 Carboplatin 2 Biopsy 2 BaseLine dental cement 2 Anastrozole 2 trametinib 1 sotorasib 1 semaglutide 1 selpercatinib 1 pembrolizumab 1 osimertinib 1 lorlatinib 1 dabrafenib 1 cemiplimab 1 bupropion hydrochloride, naltrexone hydrochoride drug combination 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Counseling × Other × Clear all

NCT01294657 2019-05-10

Obesity: Cancer Risk Among African Americans

M.D. Anderson Cancer Center

Motor Activity, Neoplasms, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡